Product Information
DEXTROAMPHETAMINE 5 MG/5 ML is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $1.1434 per ML under NDC 27808008501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 29, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808008501
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203644FDA Approved
5/29/2013
TE Code
AA
On Market Since
5/31/2013
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE 5 MG/5 ML has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 6.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1434 per ML |
|---|---|
| All-time high | $1.6107 (Apr 16, 2014) |
| All-time low | $1.0078 (Nov 20, 2024) |
| 52-week high | $1.2220 |
| 52-week low | $1.0988 |
| Median price | $1.2983 |
| Average price | $1.3183 |
| Largest weekly change | +28.6% (Feb 19, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE 5 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE 5 MG/5 ML, manufactured by Cranbury Pharmaceuticals, LLC, is $1.1434 per ML (NDC 27808008501), effective Sep 30, 2026.
How has the price of DEXTROAMPHETAMINE 5 MG/5 ML changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE 5 MG/5 ML has declined 6.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE 5 MG/5 ML?
Since Nov 28, 2013, the NADAC for DEXTROAMPHETAMINE 5 MG/5 ML has ranged from a low of $1.0078 (Nov 20, 2024) to a high of $1.6107 (Apr 16, 2014), with a median of $1.2983 per ML.
Are there cheaper alternatives to DEXTROAMPHETAMINE 5 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPHETAMINE 5 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPHETAMINE 5 MG/5 ML?
DEXTROAMPHETAMINE 5 MG/5 ML (NDC 27808008501) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.